Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Assets (2013 - 2026)

Scynexis' (SCYX) quarterly Assets came in at $75.0 million in Q2 2026, up 23.52% on a YoY basis from $60.7 million in Q2 2025, and down 3.42% quarter-over-quarter from $77.6 million in Q1 2026.

Analysis

Scynexis (SCYX) Assets (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Assets for 14 consecutive years, with $75.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets rose 23.52% year-over-year to $75.0 million; the trailing twelve-month figure through Jun 2026 stood at $75.0 million (up 23.52% YoY), and the FY2025 full-year result was $59.0 million, down 34.88% from the prior year.
  • Assets declined to $75.0 million in Q2 2026 per SCYX's latest filing, from $77.6 million in the prior quarter.
  • Across five years, Assets topped out at $154.9 million in Q2 2023 and bottomed at $51.1 million in Q3 2025.
  • Historically, Assets has averaged $97.6 million across 5 years, with a median of $94.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Assets soared 68.22% in 2024, then tumbled 48.43% in 2025.
  • Over 5 years, Assets stood at $87.8 million in 2022, then surged by 46.24% to $128.4 million in 2023, then dropped by 29.41% to $90.6 million in 2024, then tumbled by 34.88% to $59.0 million in 2025, then rose by 27.01% to $75.0 million in 2026.
  • According to Business Quant data, Assets over the past three periods registered $75.0 million, $77.6 million, and $59.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 10.03 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.31 Bn
10 Scynexis 58.41 Mn -56.29 Mn - 74.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.97 Mn
Mar 31, 2026 77.63 Mn
Dec 31, 2025 59.03 Mn
Sep 30, 2025 51.07 Mn
Jun 30, 2025 60.69 Mn
Mar 31, 2025 67.92 Mn
Dec 31, 2024 90.64 Mn
Sep 30, 2024 99.04 Mn
Jun 30, 2024 107.81 Mn
Mar 31, 2024 118.25 Mn
Dec 31, 2023 128.41 Mn
Sep 30, 2023 148.55 Mn
Jun 30, 2023 154.86 Mn
Mar 31, 2023 70.30 Mn
Dec 31, 2022 87.81 Mn
Sep 30, 2022 112.29 Mn
Jun 30, 2022 135.61 Mn
Mar 31, 2022 111.56 Mn
Dec 31, 2021 119.84 Mn
Sep 30, 2021 109.88 Mn